These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6607465)

  • 21. [Experimental and clinical data on the ototoxic properties of aminoglycoside antibiotics (aminocyclitols)].
    Berezhinskaia VV; Dolgova GV; Eĭromdzhants AA; Firsov AA; Berezina EK
    Antibiotiki; 1983 Mar; 28(3):218-29. PubMed ID: 6344782
    [No Abstract]   [Full Text] [Related]  

  • 22. Aminoglycoside ototoxicity in the neonatal period: possible etiologic factor delayed postural control.
    Eviatar L; Eviatar A
    Otolaryngol Head Neck Surg; 1981; 89(5):818-21. PubMed ID: 6799915
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical application of aminoglycosides.
    Noone P
    Br J Audiol; 1982 May; 16(2):141-6. PubMed ID: 6980038
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum level monitoring of antibacterial drugs. A review.
    Wenk M; Vozeh S; Follath F
    Clin Pharmacokinet; 1984; 9(6):475-92. PubMed ID: 6391780
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ototoxicity.
    Ballantyne J
    J Laryngol Otol Suppl; 1983; 8():9-12. PubMed ID: 6607302
    [No Abstract]   [Full Text] [Related]  

  • 26. Suggestions for monitoring patients during treatment with aminoglycoside antibiotics.
    Lerner SA; Matz GJ
    Otolaryngol Head Neck Surg (1979); 1979; 87(2):222-8. PubMed ID: 503492
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Molecular mechanisms underlying renal accumulation of aminoglycoside antibiotics and mechanism-based approach for developing nonnephrotoxic aminoglycoside therapy].
    Nagai J
    Yakugaku Zasshi; 2006 May; 126(5):327-35. PubMed ID: 16679740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The ototoxicity of the aminoglycoside antibiotics (author's transl)].
    Kellerhals B
    Munch Med Wochenschr; 1973 Sep; 115(39):1667-72. PubMed ID: 4801048
    [No Abstract]   [Full Text] [Related]  

  • 29. Audiologic testing and molecular analysis of 12S rRNA in patients receiving aminoglycosides.
    Gürtler N; Schmuziger N; Kim Y; Mhatre AN; Jungi M; Lalwani AK
    Laryngoscope; 2005 Apr; 115(4):640-4. PubMed ID: 15805873
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extended-interval aminoglycoside dosing for treatment of enterococcal and staphylococcal osteomyelitis.
    Graham AC; Mercier RC; Achusim LE; Pai MP
    Ann Pharmacother; 2004 Jun; 38(6):936-41. PubMed ID: 15084688
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Drug-induced sudden hearing loss and vestibular disturbances.
    Federspil P
    Adv Otorhinolaryngol; 1981; 27():144-58. PubMed ID: 7034495
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Complexation versus hemodialysis to reduce elevated aminoglycoside serum concentrations.
    Schentag JJ; Simons GW; Schultz RW; Vance JW; Williams JS
    Pharmacotherapy; 1984; 4(6):374-80. PubMed ID: 6514587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A study of the cochleo-vestibular tolerance of tobramycin in man. Preliminary study].
    Brogard JM; Conraux C; Collard M; Jahn H; Lavillaureix J
    Nouv Presse Med; 1974 Apr; 3(0):75-9. PubMed ID: 4600182
    [No Abstract]   [Full Text] [Related]  

  • 34. Aminoglycosides: another perspective.
    Garrison MW; Zaske DE; Rotschafer JC
    DICP; 1990 Mar; 24(3):267-72. PubMed ID: 2180221
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of aminoglycoside serum assays on clinical decisions and renal toxicity.
    Arroyo JC; Milligan WL; Davis J; Mitchell D
    South Med J; 1986 Mar; 79(3):272-6. PubMed ID: 3513326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical evaluation of the ototoxicity of aminoglycosides. Comparison of tobramycin and gentamycin. Preliminary report].
    Fee WE
    Nouv Presse Med; 1978 Nov; 7(42):3854-5. PubMed ID: 309592
    [No Abstract]   [Full Text] [Related]  

  • 37. Protective effect of fosfomycin against aminoglycoside ototoxicity.
    Ohtani I; Ohtsuki K; Aikawa T; Sato Y; Anzai T; Ouchi J; Saito T
    ORL J Otorhinolaryngol Relat Spec; 1985; 47(1):42-8. PubMed ID: 3969267
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pathogenesis and detection of aminoglycoside ototoxicity.
    Keene M; Hawke M
    J Otolaryngol; 1981 Jun; 10(3):228-36. PubMed ID: 7024566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapeutic initiatives for the avoidance of aminoglycoside toxicity.
    Whelton A
    J Clin Pharmacol; 1985 Mar; 25(2):67-81. PubMed ID: 3886711
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Basis for an adequate dosage of aminoglycoside antibiotics.
    Lüthy R
    Infection; 1980; Suppl 1():58-61. PubMed ID: 7399715
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.